dr. (Ajay) A.S. Bhaskarabhatla

All publications (9)

• Article (8)

  • A.S. Bhaskarabhatla (2018). Stakeholder Orientation and Market Impact: Evidence from India. Journal of Business Ethics. doi: 10.1007/s10551-018-3919-x
  • A.S. Bhaskarabhatla & C. Chirantan (2017). The Role of Physicians in Prescribing Irrational Fixed-Dose Combination Medicines in India. Social Science & Medicine, 174 (February), 179-187. doi: 10.1016/j.socscimed.2016.12.022
  • A.S. Bhaskarabhatla, P. Anurag, C. Chatterjee & H.P.G. Pennings (2017). Mitigating Regulatory Impact: The Case of Partial Price Controls on Metformin in India. Health Policy and Planning, 32 (2), 194-204. doi: 10.1093/heapol/czw109
  • A.S. Bhaskarabhatla, C. Chatterjee & B. Karreman (2016). Hit where it hurts: Cartel policing using targeted sales and supply embargoes. The Journal of Law and Economics, 59 (4), 805-846. doi: 10.1086/691093
  • A.S. Bhaskarabhatla (2016). The Moderating Role of Submarket Dynamics on the Product Customization–Firm Survival Relationship. Organization Science, 27 (4), 1049-1064. doi: 10.1287/orsc.2016.1074
  • A.S. Bhaskarabhatla & H.P.G. Pennings (2014). Defensive Disclosure of Patentable Inventions under Antitrust Enforcement. Industry and Innovation, 21 (7), 533-552. doi: 10.1080/13662716.2014.987452
  • A.S. Bhaskarabhatla & D. Hegde (2014). An Organizational Perspective on Patenting and Open Innovation. Organization Science, 25 (6), 1744-1763. doi: 10.1287/orsc.2014.0911
  • A.S. Bhaskarabhatla & S. Klepper (2014). Latent Submarket Dynamics and Industry Evolution: Lessons from the U.S. Laser Industry. Industrial and Corporate Change (online version), 23 (6), 1381-1415. doi: 10.1093/icc/dtt060

• Book / Monograph / Book editorial (1)

  • A.S. Bhaskarabhatla (2018). Regulating Pharmaceutical Prices in India Policy Design, Implementation and Compliance. (India Studies in Business and Economics, 2198-0012). Springer Germany: Springer International Publishing

Ancillary activities (1)

Teaching (4)

Present position